home / stock / tcbp / tcbp news


TCBP News and Press, TC BioPharm (Holdings) plc From 07/25/22

Stock Information

Company Name: TC BioPharm (Holdings) plc
Stock Symbol: TCBP
Market: NASDAQ
Website: tcbiopharm.com

Menu

TCBP TCBP Quote TCBP Short TCBP News TCBP Articles TCBP Message Board
Get TCBP Alerts

News, Short Squeeze, Breakout and More Instantly...

TCBP - TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit

TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit PR Newswire Event Taking Place in Boston on July 26-28, 2022 EDINBURGH, Scotland , July 25, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Co...

TCBP - TC BioPharm CEO, Bryan Kobel to Speak at the "Innovating Cell and Gene Therapy Quality Control Conference 2022"

TC BioPharm CEO, Bryan Kobel to Speak at the "Innovating Cell and Gene Therapy Quality Control Conference 2022" PR Newswire Management will Participate in Fireside Chat on TC BioPharm's Journey as a Successful CGT Startup on July 13, 2022 EDINBURGH, Scotl...

TCBP - TC Biopharm Announces Closing of $4 Million Underwritten Public Offering

TC Biopharm Announces Closing of $4 Million Underwritten Public Offering PR Newswire EDINBURGH, Scotland , June 7, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnol...

TCBP - TC BioPharm slumps 36% after pricing $4M public offering

TC BioPharm (NASDAQ:TCBP) stock fell ~36% premarket June 3 after the company priced a public offering of 10M American Depositary Shares (ADSs) at $0.40 per ADS for gross proceeds of $4M. The company announcement came in a post-market June 2 release. Each ADS represents one ordinary ...

TCBP - TC BioPharm Announces Pricing of $4 Million Underwritten Public Offering

TC BioPharm Announces Pricing of $4 Million Underwritten Public Offering PR Newswire EDINBURGH, Scotland , June 2, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage ...

TCBP - TC BioPharm Highlights Need for Disruptive Treatment as Acute Myeloid Leukemia Cases Rise Globally

TC BioPharm Highlights Need for Disruptive Treatment as Acute Myeloid Leukemia Cases Rise Globally PR Newswire EDINBURGH, Scotland , May 31, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a...

TCBP - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ProShares UltraShort Bloomberg Crude Oil (NYSEARCA: SCO ) leads our gainers due to a reverse stock split. Nutanix (NASDAQ: NTNX ) stock tops our losers with its fiscal Q3 earnings release. More earnings rep...

TCBP - PLG, ZTEK and BBAI among mid-day movers

Gainers: Better Therapeutics (BTTX) +26%. America's Car-Mart (CRMT) +25%. GeoVax Labs (GOVX) +17%. Platinum Group Metals (PLG) +17%. Zentek (ZTEK) +16%. China Liberal Education Holdings (CLEU) +13%. Charge Enterprises (CRGE) +13%. Citi Trends (CTRN) +13%. Cango (CANG) +13%. Losers: Snap (SNAP...

TCBP - Kuick Research Recognizes TC BioPharm as a Key Player in the Gamma-Delta T Cell Therapy Market

Kuick Research Recognizes TC BioPharm as a Key Player in the Gamma-Delta T Cell Therapy Market PR Newswire Sector is Expected to Surpass $4 Billion by 2028 Report Highlights Promising Therapy and Rising Investment from Pharmaceutical Companies EDI...

TCBP - TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts

TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts PR Newswire Dr. Mark Bonyhadi to spearhead SAB EDINBURGH, Scotland , May 18, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company...

Previous 10 Next 10